Glucocorticoid-induced osteoporosis is bone loss caused by taking steroid medicines such as prednisone for weeks to months, and it can raise the risk of broken bones. It often affects people who need long-term steroids for conditions like asthma, autoimmune disease, or inflammatory disorders, and the early symptoms of glucocorticoid-induced osteoporosis may be easy to miss until a fracture happens. Not everyone will have the same experience. Many living with glucocorticoid-induced osteoporosis have no clear symptoms at first, but some develop back pain, height loss, or fractures after a minor fall or even normal daily activity. Treatment usually includes lowering steroid exposure when possible, calcium and vitamin D, weight-bearing exercise, and medicines that help protect bone, and serious fractures can increase illness and, in older adults, may raise the risk of death.
How many people live with Glucocorticoid-induced osteoporosis?
There is no single registry that directly counts glucocorticoid-induced osteoporosis, but widely cited estimates suggest about 1% of adults use steroid medicines long term and roughly 30% to 50% of long-term users develop this bone-thinning condition, so about 15 to 25 million adults worldwide may be living with it; this is an estimate rather than a direct count, and it can vary depending on how long-term steroid use is defined (Endotext, 2022). In the United States, long-term oral steroid use has been estimated at about 1.2% of adults, which suggests roughly 900,000 to 1.5 million adults may be living with glucocorticoid-induced osteoporosis, again as an estimate rather than a direct count (Curtis et al., 2006; Endotext, 2022).
Overview
Glucocorticoid-induced osteoporosisSymptoms
Glucocorticoid-induced osteoporosis often has no symptoms at first. Many people notice it only after a broken bone from a minor fall, sudden back pain, or loss of height. Early symptoms of glucocorticoid-induced osteoporosis can be easy to miss.
Outlook and prognosis
With glucocorticoid-induced osteoporosis, outlook is often good when steroid doses are lowered if possible and bone-protecting treatment starts early. Fracture risk can drop, pain may ease, and many people maintain mobility, though some need ongoing monitoring while taking steroids.
Causes and risk factors
Glucocorticoid-induced osteoporosis is caused by long-term or high-dose steroid medicines, especially pills. Risk rises with older age, menopause, low body weight, prior fractures, smoking, heavy alcohol use, low calcium or vitamin D, inactivity, and genetic susceptibility.
Genetic influences
Genetics can affect how strongly glucocorticoid-induced osteoporosis develops, including differences in bone strength and how the body responds to steroid treatment. Still, medicines, dose, duration, age, hormones, and lifestyle usually play a bigger role than inherited variants.
Diagnosis
Glucocorticoid-induced osteoporosis is diagnosed using your history of steroid use, risk factors, and a bone density scan. Doctors may also order spine imaging and blood tests to look for fractures, bone loss, and other possible causes.
Treatment and drugs
Treatment for glucocorticoid-induced osteoporosis usually includes lowering steroid exposure when possible, weight-bearing exercise, calcium and vitamin D, and medicines that slow bone loss or help rebuild bone. Fall prevention and bone density checks are also important.
Symptoms
Glucocorticoid-induced osteoporosis often develops quietly while someone is taking steroid medicines, so many people feel fine until a bone has become much weaker. Day to day, it can feel like nothing is wrong at first, then a sudden back ache or an unexpected fracture changes what feels safe and easy. The early symptoms of glucocorticoid-induced osteoporosis are often subtle, and some people do not notice any until height loss, posture changes, or a break after a minor injury appears. The pattern is not the same for everyone, and symptoms can show up gradually or all at once.
Early on, this might look like no clear symptoms at all. Bones can lose strength quietly for months or years, so the first sign may be pain or a fracture after a small strain or minor fall.
A sudden or ongoing ache in the middle or lower back can happen when one of the bones in the spine weakens and partly collapses. Some may notice it after bending, lifting groceries, coughing, or with no obvious injury.
Many living with glucocorticoid-induced osteoporosis seem to get shorter over time. This can happen when small fractures in the spine make the back bones settle and lose height.
The upper back may begin to round forward, making it harder to stand fully upright. For many, this can mean more fatigue with standing or walking because the body has to work harder to stay balanced.
How people usually first notice Glucocorticoid-induced osteoporosis?
Glucocorticoid-induced osteoporosis often develops quietly while someone is taking steroid medicines such as prednisone, so the first signs may not be obvious at all. Many people living with it first notice a fracture after a minor fall or even routine movement, especially in the spine, hip, or wrist, or they may develop sudden back pain, loss of height, or a more stooped posture from small spinal fractures. Because early bone loss usually causes no symptoms, doctors often first suspect it in people who have been on steroids for weeks to months and order a bone density scan before any clear warning signs appear.
Types of Glucocorticoid-induced osteoporosis
Glucocorticoid-induced osteoporosis often affects daily life quietly at first, because many people feel well until a bone becomes weak enough to break. Symptoms don’t always look the same for everyone. In practice, the main patterns are no noticeable symptoms, back problems from spine fractures, and pain or loss of function after other fragility fractures. This means the early symptoms of glucocorticoid-induced osteoporosis can be easy to miss.
Silent disease
Many people with glucocorticoid-induced osteoporosis have no clear symptoms at first, even while bone strength is falling. It may only be found after a bone density test or after a minor fall, cough, or lift leads to a fracture.
Spine fractures
Small breaks in the bones of the spine can cause sudden or gradually worsening back pain. Some may notice getting shorter over time or developing a more stooped posture as several vertebrae weaken.
Hip fractures
A hip fracture often causes strong pain in the groin or upper thigh and makes standing or walking very hard. In older adults especially, this type can quickly limit independence and may happen after a low-impact fall.
Wrist fractures
Wrist fractures are a common fragility pattern, often after trying to catch yourself during a fall. Pain, swelling, and trouble using the hand for everyday tasks like dressing or cooking are typical.
Other fractures
Glucocorticoid-induced osteoporosis can also lead to fractures in the ribs, pelvis, upper arm, or other bones after relatively minor stress. One person might struggle mostly with pain when moving, while another notices reduced mobility more than pain.
Can I slow down the onset of symptoms?
Yes—if you need steroid medicines such as prednisone, there is good evidence that bone loss and fractures from glucocorticoid-induced osteoporosis can often be delayed or reduced, though not always prevented. The most helpful steps are using the lowest steroid dose for the shortest time your doctor says is safe, staying active with weight-bearing and muscle-strengthening movement, getting enough calcium and vitamin D, not smoking, limiting alcohol, and lowering fall risk; these steps can lower risk, but they do not guarantee you will avoid weak bones. Doctors also have clear guidelines to check bone density early and, for some people, start medicine to help protect bone while they are on steroids, so acting early can make a real difference.
What genetics can tell you about symptoms
Genetics may help explain why some people taking glucocorticoids lose bone faster than others, develop more severe osteoporosis, or have fractures after a shorter time on treatment, even when the medication dose seems similar. Research suggests that inherited differences in genes involved in bone remodeling and the body’s response to steroids can influence risk, but they do not reliably predict exactly which symptoms someone will have or when they will begin. In everyday terms, genetics can give part of the picture, but age, dose and length of steroid use, menopause, nutrition, exercise, and other health conditions usually matter just as much or more.
Causes and risk factors
Bones can become more fragile after weeks or months on steroid medicines like prednisone. In glucocorticoid-induced osteoporosis, these medicines slow new bone building and speed up bone loss. Risk is higher with larger doses, longer treatment, older age, menopause, low body weight, and health problems that already weaken bone. Family history and inherited differences in bone strength can add to the risk, but steroid treatment is still the main cause. Some risks are modifiable (things you can change), others are non-modifiable (things you can’t), and smoking, heavy alcohol use, low calcium or vitamin D, and too little weight-bearing exercise can make bone loss worse.
What are the most common causes or risk factors?
The main cause of glucocorticoid-induced osteoporosis is taking steroid medicines such as prednisone, especially in higher doses, for several months or longer, or in repeated courses. The risk is higher in older adults, women after menopause, people who have already had a fracture or have low bone density, and those with a family history of osteoporosis or hip fracture. Smoking, heavy alcohol use, low calcium or vitamin D, low body weight, and not getting much weight-bearing exercise can raise the risk even more.
Environmental and biological risk factors
Glucocorticoid-induced osteoporosis is bone loss caused by steroid medicines such as prednisone. The main risk factors for glucocorticoid-induced osteoporosis usually involve how much steroid you take, how long you need it, and how strong your bones were before treatment began. Doctors often group risks into internal (biological) and external (environmental).
Larger steroid doses reduce new bone building and speed up bone breakdown. Risk rises as the daily dose goes up, especially with repeated high-dose courses.
Bone loss can begin within the first few months of steroid treatment. The chance of glucocorticoid-induced osteoporosis increases further when steroids are used for 3 months or longer.
Steroid tablets and regular injections affect the whole body more than creams or most inhalers. High-dose inhaled steroids can still add to risk, especially when combined with other steroid medicines.
Bones naturally become less dense with age, so steroids can have a stronger effect in older adults. This makes glucocorticoid-induced osteoporosis more likely later in life.
Genetic risk factors
People can respond very differently to the same steroid medicine, and part of that difference comes from inherited biology. Glucocorticoid-induced osteoporosis usually is not caused by one single gene, but by a mix of genetic traits that affect bone strength and the body’s response to glucocorticoids. Some risk factors are inherited through our genes. Researchers are still mapping the genetic risk factors for glucocorticoid-induced osteoporosis, but family history and genes involved in bone formation, collagen, vitamin D signaling, and steroid sensitivity are the main areas linked to risk.
Family history: People with a close relative who has osteoporosis or fractures after a minor fall may inherit lower baseline bone strength. That can make bone loss and fractures more likely during glucocorticoid treatment.
Bone-building genes: Inherited differences in genes that help bones grow, renew, and repair can influence how dense and sturdy bones are before treatment begins. This helps explain why steroid-related bone loss is more severe in some people than in others.
Collagen genes: Collagen is one of the main materials that gives bone its flexible strength, and inherited changes in collagen-related genes can weaken bone quality. Even if bone density is only mildly reduced, fracture risk can still be higher during glucocorticoid use.
Steroid response genes: Some inherited gene differences make bone cells more sensitive to steroid medicines, so the bone-thinning effect can be stronger. Carrying a genetic change doesn’t guarantee the condition will appear, but it may increase susceptibility.
Vitamin D pathway: Variants in genes that affect vitamin D signaling and calcium balance may change how well the body maintains bone mineral. Studies suggest these differences can add to the risk of glucocorticoid-induced osteoporosis, although results are not identical in every population.
Rare bone disorders: Rare inherited conditions that already weaken bone can greatly raise the chance of osteoporosis if glucocorticoids are needed. In these cases, fractures may happen earlier or after relatively small injuries.
Lifestyle risk factors
When someone is taking glucocorticoids, daily habits can meaningfully change how much bone is lost and how likely fractures become. The main lifestyle risk factors for glucocorticoid-induced osteoporosis are low calcium and vitamin D intake, too little weight-bearing activity, smoking, excess alcohol, and poor overall nutrition or very low body weight. In practice, how lifestyle affects glucocorticoid-induced osteoporosis is mostly through changes in bone strength, muscle function, and fall risk.
Not getting enough calcium leaves less raw material available to maintain bone while glucocorticoids are accelerating bone breakdown. A consistently low-calcium diet can increase bone loss and raise fracture risk over time.
Too little vitamin D reduces calcium absorption from the gut, which weakens the body’s ability to support bone mineralization. In people taking glucocorticoids, this can further worsen loss of bone density and fragility.
Too little walking, resistance exercise, or other weight-bearing activity reduces the mechanical signals that help bones stay strong. Inactivity also weakens muscles and balance, which increases the chance of falls and fractures.
Smoking is linked to lower bone formation and poorer bone quality, which can add to steroid-related bone loss. It also impairs overall musculoskeletal health, making fractures more likely and recovery slower.
Risk prevention
Glucocorticoid-induced osteoporosis can often be partly prevented when steroid treatment is planned early and reviewed regularly. This matters in daily life because bone loss may build quietly until a minor fall, a hard cough, or lifting groceries leads to a fracture. Prevention is about lowering risk, not eliminating it completely. For many living with glucocorticoid-induced osteoporosis, the best approach combines the lowest effective steroid dose with bone-protecting habits and medical follow-up.
Use the lowest glucocorticoid dose for the shortest time that still controls the underlying condition. If steroids are needed for longer, regular medication reviews can help reduce bone loss from glucocorticoid-induced osteoporosis.
Getting enough calcium and vitamin D helps support bone strength while taking steroids. Some people need supplements if food intake, sunlight exposure, or blood levels are not enough.
Many at higher risk need prescription treatment to help prevent fractures, especially if steroid use will last for months or if bone density is already low. This can be important even before any early symptoms of glucocorticoid-induced osteoporosis appear, because bone loss often causes no warning signs.
Walking, stair climbing, resistance training, and balance work can help maintain bone and muscle strength. These habits also lower fall risk, which is a key part of preventing fractures in glucocorticoid-induced osteoporosis.
Can you prevent Glucocorticoid-induced osteoporosis?
You cannot always fully prevent bone thinning caused by steroid medicines such as prednisone, but the risk can often be lowered. Using the lowest dose for the shortest time that still controls your illness, staying active with walking or strength exercise, not smoking, limiting alcohol, and getting enough calcium and vitamin D can all help. For some people, a doctor may also recommend bone checks or medicine to help protect the bones.
Transmission
Glucocorticoid-induced osteoporosis is not infectious, so it cannot be passed from one person to another through touch, coughing, sex, food, or shared spaces. Instead, it develops as a side effect of taking glucocorticoid medicines such as prednisone, especially when they are used for longer periods or at higher doses.
If you are wondering how glucocorticoid-induced osteoporosis is transmitted, it is not really transmitted at all; the main risk comes from exposure to these steroid medicines, not from other people. Family history can affect your overall bone strength, but glucocorticoid-induced osteoporosis itself is usually related to treatment rather than being directly inherited.
When to test your genes
Routine genetic testing is not recommended for glucocorticoid-induced osteoporosis; early detection is based on your steroid dose and duration, fracture history, and bone density testing. If bone loss is unusually severe, happens young, or runs strongly in your family, your clinician may consider genetic evaluation for an underlying bone disorder.
Diagnosis
Glucocorticoid-induced osteoporosis is usually diagnosed after someone has been taking steroid medicines and shows bone loss, a low-trauma fracture, or both. A fall from standing height that leads to a broken wrist or spine can be an early clue, even if day-to-day symptoms seemed mild before. Getting a diagnosis is often a turning point toward answers and support, especially because the diagnosis of glucocorticoid-induced osteoporosis often depends on combining medication history with bone testing.
Doctors ask about current or past steroid use, including the dose and how long it has been needed. They also review age, menopause status, prior fractures, smoking, alcohol use, and other health problems that can weaken bone.
Many living with glucocorticoid-induced osteoporosis have no clear symptoms until a fracture happens. Doctors ask about back pain, loss of height, or fractures after minor bumps or falls because these can point to weakened bones.
A DXA scan is the main test used to measure bone strength at the hip and spine. This painless exam can show bone loss early and helps doctors judge how severe the osteoporosis may be.
X-rays or a spine check done with the bone density scan may be used to look for small spinal fractures. These fractures can happen silently, so imaging findings may reveal damage even when pain is mild or absent.
How is Glucocorticoid-induced osteoporosis diagnosed?
Glucocorticoid-induced osteoporosis, which means bone loss caused by steroid medicines such as prednisone, is usually diagnosed by looking at how long and how much of the medicine someone has taken, whether they have had broken bones from a minor fall or bump, and whether there are warning signs like back pain or loss of height. Doctors often confirm it with a bone density test, a low-dose X-ray scan that measures how strong the bones are, and they may also order spine X-rays and blood tests to check for fractures or other causes of weak bones. Genetic testing is not usually needed to diagnose this condition.
Stages of Glucocorticoid-induced osteoporosis
Glucocorticoid-induced osteoporosis does not have defined progression stages. This is because it is usually identified by bone loss and fracture risk over time, rather than by a set sequence of changing stages that people can clearly feel day to day. Often the process begins when you notice changes in daily life, such as back pain after a small strain or a fracture after a minor fall, although early symptoms of glucocorticoid-induced osteoporosis are often not obvious. Doctors usually diagnose and monitor glucocorticoid-induced osteoporosis using a review of steroid use, fracture history, bone density scans, and sometimes blood tests to look for other causes of weak bones.
Outlook and prognosis
With prompt prevention and treatment, the outlook for glucocorticoid-induced osteoporosis is often favorable because bone loss can slow and fracture risk can fall once glucocorticoid exposure is reduced, calcium and vitamin D status is optimized, and anti-osteoporosis therapy is used when indicated. The prognosis is worse when high-dose or long-term steroids continue, especially in older adults and people with prior fractures, because vertebral and hip fractures can occur early and may lead to chronic pain, loss of mobility, and reduced independence. Some recovery of bone mineral density is possible after steroids are tapered or stopped, but it may be incomplete, particularly after prolonged exposure. Mortality is not usually caused directly by the osteoporosis itself, yet major fragility fractures, especially hip fractures, are associated with increased illness and a higher risk of death in the months to years afterward. Regular monitoring and early treatment substantially improve long-term outcomes.
Long-term effects
Glucocorticoid-induced osteoporosis can have lasting effects on bones and day-to-day function, especially if steroid treatment continues for months or years. Many people do not notice a problem until a fracture happens after a small fall, twisting movement, or even routine activity like lifting groceries. Thinking about the long-term effects helps explain why this condition can affect mobility, comfort, and independence over time.
The main long-term effect of glucocorticoid-induced osteoporosis is a higher risk of broken bones from minor stress or low-impact falls. Fractures often affect the spine, hip, ribs, pelvis, or wrist, and they can happen earlier than many people expect.
Repeated compression fractures in the spine can lead to height loss, a stooped posture, and a back that tires more easily during everyday tasks. The early symptoms of glucocorticoid-induced osteoporosis are often easy to miss, so these changes may build up before the condition is recognized.
Ongoing back pain or pain after a fracture can last well beyond the original injury. For many, symptoms can make walking, bending, getting dressed, or sleeping comfortably more difficult.
After a fracture, some people need weeks to months to regain strength and confidence with movement. This can lead to less activity, weaker muscles, and a greater chance of future falls and more fractures.
How is it to live with Glucocorticoid-induced osteoporosis?
Living with glucocorticoid-induced osteoporosis can be unsettling because the bones may grow weaker quietly, often without any obvious warning until back pain, height loss, or a fracture changes daily life. For many, this can mean being more cautious with lifting, exercise, and fall risks, while also juggling the condition that made steroid treatment necessary in the first place. It can affect the people around you too, since family members may help with chores, transportation, or recovery after fractures, but with bone-protective treatment, movement, and fall prevention, many people are able to stay active and independent.
Treatment and drugs
Glucocorticoid-induced osteoporosis is treated by lowering fracture risk and helping keep bones as strong as possible, especially for people who need steroid medicines for asthma, autoimmune disease, or other long-term conditions. Treatment often starts with using the lowest steroid dose that still controls the underlying illness, along with enough calcium and vitamin D, regular weight-bearing exercise, avoiding smoking, and limiting alcohol. Doctors sometimes recommend a combination of lifestyle changes and drugs. These drugs may include bone-strengthening medicines, most often bisphosphonates, and in some cases other options if fracture risk is high, if bone loss is severe, or if the first treatment is not a good fit. Because bone loss can begin early after starting steroids, many living with glucocorticoid-induced osteoporosis also need bone density checks and follow-up visits so treatment can be adjusted over time.
Can you cure Glucocorticoid-induced osteoporosis?
No, glucocorticoid-induced osteoporosis, meaning bone loss caused by steroid medicines, usually cannot be fully cured. But it can often be improved and managed by lowering the steroid dose when safe, treating the underlying illness, and using bone-strengthening care such as calcium, vitamin D, exercise, and medicines that help lower the risk of broken bones.
Non-drug treatment
Living with glucocorticoid-induced osteoporosis can mean worrying about fractures during everyday things like stepping off a curb, lifting groceries, or catching yourself after a slip. Non-drug treatments often lay the foundation for protecting bone strength, improving balance, and lowering the chance of falls. For many, this also means paying attention to food, movement, and home safety while long-term steroid treatment continues. If you are looking into early symptoms of glucocorticoid-induced osteoporosis, these approaches are still important because bone loss can develop before a fracture happens.
Weight-bearing and resistance exercise can help slow further bone loss and keep muscles stronger. For many, this means walking, climbing stairs, using light weights, or doing guided strength work several times a week.
Balance and posture exercises can lower the risk of falls and help you move with more confidence. Tai chi, supervised balance drills, and gentle core work are often useful, especially for many living with glucocorticoid-induced osteoporosis who feel unsteady.
A physical therapist can build a safe program that matches your strength, pain level, and fracture risk. Supportive therapies can also teach safer ways to bend, lift, stand up, and protect the spine during daily tasks.
Eating enough calcium and getting adequate vitamin D support the body’s ability to maintain bone. This may include dairy foods or fortified alternatives, leafy greens, and safe sunlight exposure when appropriate.
Your genes may have an impact on how drugs work for you
For people living with glucocorticoid-induced osteoporosis, the medicines used to protect bones do not work exactly the same way for everyone, and part of that difference may come from small inherited changes in the body that affect how bone is built, broken down, or how a medicine is handled. For example, some may gain bone strength more easily with standard treatment, while others may need closer follow-up because bone loss continues or side effects are more likely. This kind of gene-and-medicine matching, called pharmacogenomics, is still not a routine part of care for this condition, so treatment is usually guided more by bone density results, fracture history, steroid dose, and overall health than by genetic testing.
Pharmacological treatments
For many living with glucocorticoid-induced osteoporosis, treatment is aimed at lowering the chance of painful fractures while steroid treatment continues or after it ends. The medicines used are often the same bone-strengthening drugs used for other forms of osteoporosis, but the choice depends on fracture risk, age, and whether someone can take tablets safely. First-line medications are those doctors usually try first, based on how well they prevent spine and hip fractures. Calcium and vitamin D are usually added if intake is low, but they are support treatments rather than the main drugs for glucocorticoid-induced osteoporosis.
Alendronate and risedronate are common first-choice tablets, and zoledronic acid is a once-yearly IV option when pills are hard to tolerate or not suitable. These drugs slow bone breakdown and help lower the risk of spine and other fractures in glucocorticoid-induced osteoporosis.
Teriparatide is a daily injection that helps the body build new bone, rather than mainly slowing bone loss. It may be recommended for people at very high fracture risk, especially after a spine fracture or when early treatment for glucocorticoid-induced osteoporosis needs a stronger bone-building approach.
Denosumab is an injection given every 6 months that reduces bone breakdown and can improve bone density. It may be used when bisphosphonates are not a good fit, but treatment needs planning because bone loss can rebound if it is stopped suddenly.
Calcium and vitamin D supplements are often used when food intake, absorption, or blood levels are low. They do not usually treat glucocorticoid-induced osteoporosis by themselves, but they support other medicines and help keep bone mineralization on track.
Genetic influences
People living with glucocorticoid-induced osteoporosis can have very different amounts of bone loss, even when they take similar steroid medicines for a similar length of time. Genetics is only one piece of the puzzle, but inherited differences in bone strength, vitamin D handling, and the way the body responds to glucocorticoids may help explain who is more likely to develop glucocorticoid-induced osteoporosis. If osteoporosis or broken bones are common in your family, that can add to risk, especially after months of treatment with medicines such as prednisone. Researchers have linked some gene changes to bone turnover and steroid sensitivity, but there is no single gene test that can reliably predict glucocorticoid-induced osteoporosis in routine care. For many, this can mean that two people on the same dose have different outcomes: one may have mild bone thinning, while another has a fracture after a small fall. In practice, doctors usually consider family history along with age, steroid dose and duration, menopause status, nutrition, exercise, and other health conditions rather than relying on genetics alone.
Is Glucocorticoid-induced osteoporosis genetic?
Genetics can affect how strongly glucocorticoid-induced osteoporosis develops, including differences in bone strength and how the body responds to steroid treatment. Still, medicines, dose, duration, age, hormones, and lifestyle usually play a bigger role than inherited variants.
Having a genetic risk is not necessarily a diagnosis
Genetic variants are a common, normal part of human biology. Most do not have a direct effect on health and simply reflect natural human diversity. For many genes, having a variant linked to a condition suggests a possible association rather than a definite diagnosis, especially when more than one gene and environmental factors are involved. In some situations, though, a single well-characterized variant in a specific gene is enough to confirm a diagnosis.
Pharmacogenetics—how genetics influence drug effects
People taking long-term steroids for asthma, autoimmune disease, or after an organ transplant can have very different amounts of bone loss, even when their treatment looks similar on paper. Part of that difference may come from genes that affect how bone is broken down and rebuilt, how sensitive bone cells are to steroids, and how the body uses vitamin D and calcium.
In glucocorticoid-induced osteoporosis, these inherited differences may help explain why treatment for glucocorticoid-induced osteoporosis works better for some people than others, including response to medicines that slow bone breakdown or help build new bone. Not every difference in response is genetic, but doctors do not routinely use genetic testing to choose osteoporosis drugs, because bone density, fracture history, steroid dose and duration, kidney function, age, and menopause usually matter more. If bone loss is unusually severe or fractures happen despite treatment, your clinician may look for an inherited bone condition or another medical cause that could change the treatment plan.
Interactions with other conditions
People living with glucocorticoid-induced osteoporosis often also have the inflammatory or autoimmune condition that led to steroid treatment in the first place, such as asthma, rheumatoid arthritis, or lupus, and that can make bone health harder to protect. The underlying illness itself may raise fracture risk through inflammation, reduced movement, or poor nutrition, while the steroid medicine adds another layer of bone loss. Day-to-day, it can feel like one health issue amplifies the other, especially if back pain, height loss, or fractures make it harder to stay active and manage the original condition. Glucocorticoid-induced osteoporosis also matters more in people with other causes of weak bones, including low vitamin D, kidney disease, low body weight, hormone changes after menopause, or low testosterone. Some may find that diabetes, digestive disorders that reduce nutrient absorption, or long periods of immobility further increase the chance of fractures and slow recovery after one happens. Because of this overlap, doctors usually look at the whole picture rather than bone density alone when assessing fracture risk and planning treatment.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
What other conditions can cause similar symptoms to Glucocorticoid-induced osteoporosis?
Other causes of weak, fracture-prone bones can look very similar, especially common age-related osteoporosis, including bone loss after menopause. Doctors may also check for low vitamin D, problems with hormone glands such as an overactive thyroid or parathyroid, and low sex hormone levels, because these can also lead to back pain, loss of height, or broken bones after a minor fall. In some cases, they also need to rule out less common but important causes of bone pain or fractures, such as cancers that affect the bone.
History
People living with glucocorticoid-induced osteoporosis often do not notice anything at first. The condition usually came to medical attention when someone taking steroid medicines for asthma, arthritis, or an autoimmune condition developed back pain, lost height, or had a fracture after a minor fall. Doctors gradually recognized that these medicines, while often essential, could also weaken bone over time.
Since the earliest days of medicine, efforts have been made to understand the effects of long-term steroid treatment. Once considered rare, now recognized as a common treatment-related bone problem, glucocorticoid-induced osteoporosis became more clearly described in the second half of the 20th century, as steroid medicines were used more widely and for longer periods. Early reports linked these drugs to thinning bones and spine fractures, especially in people taking higher doses or using them for many months.
As medical science evolved, researchers learned that bone loss can begin surprisingly early after starting glucocorticoids, sometimes within the first few months. This helped explain why some people developed fractures even before a bone density scan looked severely abnormal. Over time, doctors also saw that risk varies from one person to another, depending on age, dose, other health conditions, and whether someone had already had a fracture.
In recent decades, awareness has grown around prevention. Medical groups developed guidance on checking bone health, using the lowest effective steroid dose when possible, and considering treatments to protect bone in people at higher risk. Knowing the condition’s history helps explain why early symptoms of glucocorticoid-induced osteoporosis can be easy to miss, and why bone protection is now part of routine care for many who need long-term steroid treatment.